{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T07:44:44Z","timestamp":1791359084765,"version":"4.3.1"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2024,5,6]],"date-time":"2024-05-06T00:00:00Z","timestamp":1714953600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2024,5,6]],"date-time":"2024-05-06T00:00:00Z","timestamp":1714953600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Infect Dis Ther"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1007\/s40121-024-00974-7","type":"journal-article","created":{"date-parts":[[2024,5,24]],"date-time":"2024-05-24T13:02:26Z","timestamp":1716555746000},"page":"1399-1417","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Respiratory Syncytial Virus Sequelae Among Adults in High-Income Countries: A Systematic Literature Review and Meta-analysis"],"prefix":"10.1007","volume":"13","author":[{"given":"Egbe","family":"Ubamadu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Estefania","family":"Betancur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bradford D.","family":"Gessner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonia","family":"Menon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hilde","family":"Vroling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Curcio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Rozenbaum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samantha K.","family":"Kurosky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zuleika","family":"Aponte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1287-5416","authenticated-orcid":false,"given":"Elizabeth","family":"Begier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,5,6]]},"reference":[{"key":"974_CR1","unstructured":"Public Health England. Respiratory syncytial virus. In: Respiratory syncytial virus: the green book [Internet]. 2015. https:\/\/assets.publishing.service.gov.uk\/government\/uploads\/system\/uploads\/attachment_data\/file\/458469\/Green_Book_Chapter_27a_v2_0W.PDF. Accessed 16 June 2022."},{"key":"974_CR2","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/j.ijid.2020.11.185","volume":"103","author":"A Atamna","year":"2021","unstructured":"Atamna A, Babich T, Froimovici D, et al. Morbidity and mortality of respiratory syncytial virus infection in hospitalized adults: comparison with seasonal influenza. Int J Infect Dis. 2021;103:489\u201393.","journal-title":"Int J Infect Dis"},{"issue":"4","key":"974_CR3","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1007\/s40121-023-00792-3","volume":"12","author":"Y Li","year":"2023","unstructured":"Li Y, Kulkarni D, Begier E, et al. Adjusting for case under-ascertainment in estimating RSV hospitalisation burden of older adults in high-income countries: a systematic review and modelling study. Infect Dis Ther. 2023;12(4):1137\u201349.","journal-title":"Infect Dis Ther"},{"key":"974_CR4","doi-asserted-by":"publisher","DOI":"10.1038\/d41573-023-00085-x","author":"K Kingwell","year":"2023","unstructured":"Kingwell K. RSV vaccines score landmark FDA approvals. Nat Rev Drug Discov. 2023. https:\/\/doi.org\/10.1038\/d41573-023-00085-x.","journal-title":"Nat Rev Drug Discov"},{"issue":"3","key":"974_CR5","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1093\/infdis\/jiab003","volume":"226","author":"J Sadoff","year":"2022","unstructured":"Sadoff J, De Paepe E, DeVincenzo J, et al. Prevention of respiratory syncytial virus infection in healthy adults by a single immunization of Ad26.RSV.preF in a human challenge study. J Infect Dis. 2022;226(3):396\u2013406.","journal-title":"J Infect Dis"},{"issue":"4","key":"974_CR6","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1111\/irv.12850","volume":"15","author":"J Shan","year":"2021","unstructured":"Shan J, Britton PN, King CL, Booy R. The immunogenicity and safety of respiratory syncytial virus vaccines in development: a systematic review. Influ Other Respir Viruses. 2021;15(4):539\u201351.","journal-title":"Influ Other Respir Viruses"},{"key":"974_CR7","doi-asserted-by":"publisher","first-page":"e48","DOI":"10.1017\/S0950268820000400","volume":"148","author":"M Tin Tin Htar","year":"2020","unstructured":"Tin Tin Htar M, Yerramalla MS, Mo\u00efsi JC, Swerdlow DL. The burden of respiratory syncytial virus in adults: a systematic review and meta-analysis. Epidemiol Infect. 2020;148:e48.","journal-title":"Epidemiol Infect"},{"issue":"5","key":"974_CR8","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1111\/irv.12470","volume":"11","author":"SA Sellers","year":"2017","unstructured":"Sellers SA, Hagan RS, Hayden FG, Fischer Ii WA. The hidden burden of influenza: a review of the extra-pulmonary complications of influenza infection. Influ Other Respir Viruses. 2017;11(5):372\u201393.","journal-title":"Influ Other Respir Viruses"},{"issue":"2","key":"974_CR9","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1038\/s41590-021-01104-y","volume":"23","author":"S Mehandru","year":"2022","unstructured":"Mehandru S, Merad M. Pathological sequelae of long-haul COVID. Nat Immunol. 2022;23(2):194\u2013202.","journal-title":"Nat Immunol"},{"key":"974_CR10","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.g7647","volume":"349","author":"L Shamseer","year":"2015","unstructured":"Shamseer L, Moher D, Clarke M, et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation. BMJ. 2015;349:g7647.","journal-title":"BMJ"},{"issue":"158","key":"974_CR11","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1080\/01621459.1927.10502953","volume":"22","author":"EB Wilson","year":"1927","unstructured":"Wilson EB. Probable inference, the law of succession, and statistical inference. J Am Stat Assoc. 1927;22(158):209\u201312.","journal-title":"J Am Stat Assoc"},{"issue":"11","key":"974_CR12","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1002\/sim.1186","volume":"21","author":"JPT Higgins","year":"2002","unstructured":"Higgins JPT, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21(11):1539\u201358.","journal-title":"Stat Med"},{"key":"974_CR13","unstructured":"RStudio-Team. RStudio: Integrated Development for R Boston: RStudio, PBC; 2020. http:\/\/www.rstudio.com\/. Accessed 16 June 2022."},{"issue":"2","key":"974_CR14","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1093\/cid\/ciy991","volume":"69","author":"B Ackerson","year":"2019","unstructured":"Ackerson B, Tseng HF, Sy LS, et al. Severe morbidity and mortality associated with respiratory syncytial virus versus influenza infection in hospitalized older adults. Clin Infect Dis. 2019;69(2):197\u2013203.","journal-title":"Clin Infect Dis"},{"issue":"6","key":"974_CR15","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1111\/irv.13043","volume":"16","author":"AR Branche","year":"2022","unstructured":"Branche AR, Saiman L, Walsh EE, et al. Change in functional status associated with respiratory syncytial virus infection in hospitalized older adults. Influ Other Respir Viruses. 2022;16(6):1151\u201360.","journal-title":"Influ Other Respir Viruses"},{"issue":"suppl_1","key":"974_CR16","doi-asserted-by":"publisher","first-page":"S263","DOI":"10.1093\/ofid\/ofy210.740","volume":"5","author":"A Branche","year":"2018","unstructured":"Branche A, Granieri E, Walsh E, et al. Incidence and evaluation of the change in functional status associated with respiratory syncytial virus infection in hospitalized older adults. Open Forum Infect Dis. 2018;5(suppl_1):S263.","journal-title":"Open Forum Infect Dis"},{"issue":"7","key":"974_CR17","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1016\/j.healun.2015.01.009","volume":"34","author":"FS Burrows","year":"2015","unstructured":"Burrows FS, Carlos LM, Benzimra M, et al. Oral ribavirin for respiratory syncytial virus infection after lung transplantation: efficacy and cost-efficiency. J Heart Lung Transplant. 2015;34(7):958\u201362.","journal-title":"J Heart Lung Transplant"},{"issue":"7","key":"974_CR18","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0253161","volume":"16","author":"M Chorazka","year":"2021","unstructured":"Chorazka M, Flury D, Herzog K, Albrich WC, Vuichard-Gysin D. Clinical outcomes of adults hospitalized for laboratory confirmed respiratory syncytial virus or influenza virus infection. PLoS ONE. 2021;16(7):e0253161.","journal-title":"PLoS ONE"},{"issue":"2","key":"974_CR19","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1111\/tid.12513","volume":"18","author":"M Damlaj","year":"2016","unstructured":"Damlaj M, Bartoo G, Cartin-Ceba R, et al. Corticosteroid use as adjunct therapy for respiratory syncytial virus infection in adult allogeneic stem cell transplant recipients. Transpl Infect Dis. 2016;18(2):216\u201326.","journal-title":"Transpl Infect Dis"},{"issue":"S2","key":"974_CR20","first-page":"201","volume":"26","author":"M Han","year":"2021","unstructured":"Han M, Smyth L, Schembri S. Effect of respiratory syncytial virus infection compared to influenza infection on cardiovascular events. Respirology. 2021;26(S2):201.","journal-title":"Respirology"},{"issue":"8","key":"974_CR21","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1164\/rccm.200711-1657OC","volume":"178","author":"P Hopkins","year":"2008","unstructured":"Hopkins P, McNeil K, Kermeen F, et al. Human metapneumovirus in lung transplant recipients and comparison to respiratory syncytial virus. Am J Respir Crit Care Med. 2008;178(8):876\u201381.","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"974_CR22","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1164\/rccm.200310-1359OC","volume":"170","author":"AP Khalifah","year":"2004","unstructured":"Khalifah AP, Hachem RR, Chakinala MM, et al. Respiratory viral infections are a distinct risk for bronchiolitis obliterans syndrome and death. Am J Respir Crit Care Med. 2004;170(2):181\u20137.","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"974_CR23","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1097\/00004728-200003000-00009","volume":"24","author":"JP Ko","year":"2000","unstructured":"Ko JP, Shepard J-AO, Sproule MW, et al. CT manifestations of respiratory syncytial virus infection in lung transplant recipients. J Comput Assist Tomogr. 2000;24(2):235.","journal-title":"J Comput Assist Tomogr"},{"key":"974_CR24","first-page":"30","volume":"30","author":"H Lafoeste","year":"2017","unstructured":"Lafoeste H, Picard C, Azuar-Beaumont L, et al. Impact of respiratory syncytial virus infection on long-term outcomes in lung transplant recipients. Transpl Int. 2017;30:30.","journal-title":"Transpl Int"},{"issue":"4","key":"974_CR25","doi-asserted-by":"publisher","DOI":"10.1111\/tid.13661","volume":"23","author":"LD Mahan","year":"2021","unstructured":"Mahan LD, Points A, Mohanka MR, et al. Characteristics and outcomes among lung transplant patients with respiratory syncytial virus infection. Transpl Infect Dis. 2021;23(4):e13661.","journal-title":"Transpl Infect Dis"},{"issue":"4","key":"974_CR26","doi-asserted-by":"publisher","first-page":"S312","DOI":"10.1016\/j.healun.2019.01.788","volume":"38","author":"N Permpalung","year":"2019","unstructured":"Permpalung N, Thaniyavarn T, Saullo JH, et al. Impact of respiratory syncytial virus infection on bronchiolitis obliterans syndrome in lung transplant recipients. J Heart Lung Transplant. 2019;38(4):S312\u20133.","journal-title":"J Heart Lung Transplant"},{"issue":"4","key":"974_CR27","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1016\/j.bbmt.2012.12.019","volume":"19","author":"S Seo","year":"2013","unstructured":"Seo S, Campbell AP, Xie H, et al. Outcome of respiratory syncytial virus lower respiratory tract disease in hematopoietic cell transplant recipients receiving aerosolized ribavirin: significance of stem cell source and oxygen requirement. Biol Blood Marrow Transplant. 2013;19(4):589\u201396.","journal-title":"Biol Blood Marrow Transplant"},{"issue":"4","key":"974_CR28","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1016\/j.bbmt.2018.11.022","volume":"25","author":"A Sheshadri","year":"2019","unstructured":"Sheshadri A, Chemaly RF, Alousi AM, et al. Pulmonary impairment after respiratory viral infections is associated with high mortality in allogeneic hematopoietic cell transplant recipients. Biol Blood Marrow Transplant. 2019;25(4):800\u20139.","journal-title":"Biol Blood Marrow Transplant"},{"issue":"6","key":"974_CR29","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1016\/j.cmi.2020.07.050","volume":"27","author":"H Testaert","year":"2021","unstructured":"Testaert H, Bouet M, Valour F, et al. Incidence, management and outcome of respiratory syncytial virus infection in adult lung transplant recipients: a 9-year retrospective multicentre study. Clin Microbiol Infect. 2021;27(6):897\u2013903.","journal-title":"Clin Microbiol Infect"},{"issue":"3","key":"974_CR30","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1007\/s12325-020-01230-3","volume":"37","author":"V Wyffels","year":"2020","unstructured":"Wyffels V, Kariburyo F, Gavart S, Fleischhackl R, Yuce H. A real-world analysis of patient characteristics and predictors of hospitalization among us medicare beneficiaries with respiratory syncytial virus infection. Adv Ther. 2020;37(3):1203\u201317.","journal-title":"Adv Ther"},{"issue":"3","key":"974_CR31","doi-asserted-by":"publisher","first-page":"2100651","DOI":"10.1183\/13993003.00651-2021","volume":"59","author":"A Descamps","year":"2022","unstructured":"Descamps A, Lenzi N, Galtier F, et al. In-hospital and midterm post-discharge complications of adults hospitalised with respiratory syncytial virus infection in France, 2017\u20132019: an observational study. Eur Respir J. 2022;59(3):2100651.","journal-title":"Eur Respir J"},{"issue":"9","key":"974_CR32","doi-asserted-by":"publisher","first-page":"2702","DOI":"10.1016\/j.transproceed.2021.08.037","volume":"53","author":"M Mart\u00edn-Cerezuela","year":"2021","unstructured":"Mart\u00edn-Cerezuela M, Cu\u00e9llar-Monreal MJ, Monte-Boquet E, Sol\u00e9-Jover A, Poveda-Andr\u00e9s JL. Oral ribavirin for treatment of respiratory syncytial virus in lung transplantation recipients. Transpl Proc. 2021;53(9):2702\u20135.","journal-title":"Transpl Proc"},{"issue":"3","key":"974_CR33","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.healun.2009.08.012","volume":"29","author":"I U\u00e7kay","year":"2010","unstructured":"U\u00e7kay I, Gasche-Soccal PM, Kaiser L, et al. Low incidence of severe respiratory syncytial virus infections in lung transplant recipients despite the absence of specific therapy. J Heart Lung Transplant. 2010;29(3):299\u2013305.","journal-title":"J Heart Lung Transplant"},{"issue":"2","key":"974_CR34","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.healun.2015.08.012","volume":"35","author":"J Gottlieb","year":"2016","unstructured":"Gottlieb J, Zamora MR, Hodges T, et al. ALN-RSV01 for prevention of bronchiolitis obliterans syndrome after respiratory syncytial virus infection in lung transplant recipients. J Heart Lung Transplant. 2016;35(2):213\u201321.","journal-title":"J Heart Lung Transplant"},{"issue":"45","key":"974_CR35","doi-asserted-by":"publisher","first-page":"1695","DOI":"10.15585\/mmwr.mm6945e2","volume":"69","author":"AM Lavery","year":"2020","unstructured":"Lavery AM, Preston LE, Ko JY, et al. Characteristics of hospitalized COVID-19 patients discharged and experiencing same-hospital readmission - United States, March-August 2020. MMWR Morb Mortal Wkly Rep. 2020;69(45):1695\u20139.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"6","key":"974_CR36","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1007\/s11606-017-4301-x","volume":"33","author":"TD Girard","year":"2018","unstructured":"Girard TD, Self WH, Edwards KM, et al. Long-term cognitive impairment after hospitalization for community-acquired pneumonia: a prospective cohort study. J Gen Intern Med. 2018;33(6):929\u201335.","journal-title":"J Gen Intern Med"},{"issue":"6","key":"974_CR37","doi-asserted-by":"publisher","DOI":"10.1111\/tid.13739","volume":"23","author":"LD Mahan","year":"2021","unstructured":"Mahan LD, Lill I, Halverson Q, et al. Post-infection pulmonary sequelae after COVID-19 among patients with lung transplantation. Transpl Infect Dis. 2021;23(6):e13739.","journal-title":"Transpl Infect Dis"},{"issue":"1","key":"974_CR38","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1111\/cei.12881","volume":"187","author":"DM Boe","year":"2017","unstructured":"Boe DM, Boule LA, Kovacs EJ. Innate immune responses in the ageing lung. Clin Exp Immunol. 2017;187(1):16\u201325.","journal-title":"Clin Exp Immunol"},{"issue":"4","key":"974_CR39","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1093\/infdis\/jiaa117","volume":"222","author":"DM Dobrzynski Jr","year":"2020","unstructured":"Dobrzynski DM Jr, Ndi DN, Zhu Y, Markus T, Schaffner W, Talbot HK. Hospital readmissions after laboratory-confirmed influenza hospitalization. J Infect Dis. 2020;222(4):583\u20139.","journal-title":"J Infect Dis"},{"issue":"1","key":"974_CR40","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1002\/jmv.27281","volume":"94","author":"S Sotoodeh Ghorbani","year":"2022","unstructured":"Sotoodeh Ghorbani S, Taherpour N, Bayat S, Ghajari H, Mohseni P, Hashemi Nazari SS. Epidemiologic characteristics of cases with reinfection, recurrence, and hospital readmission due to COVID-19: a systematic review and meta-analysis. J Med Virol. 2022;94(1):44\u201353.","journal-title":"J Med Virol"},{"issue":"8","key":"974_CR41","doi-asserted-by":"publisher","first-page":"2031","DOI":"10.1111\/j.1600-6143.2005.00971.x","volume":"5","author":"D Kumar","year":"2005","unstructured":"Kumar D, Erdman D, Keshavjee S, et al. Clinical impact of community-acquired respiratory viruses on bronchiolitis obliterans after lung transplant. Am J Transplant. 2005;5(8):2031\u20136.","journal-title":"Am J Transplant"},{"issue":"11","key":"974_CR42","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1080\/14760584.2019.1690459","volume":"18","author":"D Caldeira","year":"2019","unstructured":"Caldeira D, Rodrigues B, David C, Costa J, Pinto FJ, Ferreira JJ. The association of influenza infection and vaccine with myocardial infarction: systematic review and meta-analysis of self-controlled case series. Expert Rev Vaccines. 2019;18(11):1211\u20137.","journal-title":"Expert Rev Vaccines"},{"issue":"24","key":"974_CR43","doi-asserted-by":"publisher","first-page":"1953","DOI":"10.1136\/heartjnl-2016-309983","volume":"102","author":"CR MacIntyre","year":"2016","unstructured":"MacIntyre CR, Mahimbo A, Moa AM, Barnes M. Influenza vaccine as a coronary intervention for prevention of myocardial infarction. Heart. 2016;102(24):1953\u20136.","journal-title":"Heart"},{"issue":"1","key":"974_CR44","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1007\/s10741-018-9736-6","volume":"24","author":"H Fukuta","year":"2019","unstructured":"Fukuta H, Goto T, Wakami K, Kamiya T, Ohte N. The effect of influenza vaccination on mortality and hospitalization in patients with heart failure: a systematic review and meta-analysis. Heart Fail Rev. 2019;24(1):109\u201314.","journal-title":"Heart Fail Rev"},{"issue":"6","key":"974_CR45","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.120.019636","volume":"10","author":"SH Yedlapati","year":"2021","unstructured":"Yedlapati SH, Khan SU, Talluri S, et al. Effects of influenza vaccine on mortality and cardiovascular outcomes in patients with cardiovascular disease: a systematic review and meta-analysis. J Am Heart Assoc. 2021;10(6):e019636.","journal-title":"J Am Heart Assoc"},{"key":"974_CR46","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.875691","author":"S Pischedda","year":"2022","unstructured":"Pischedda S, Rivero-Calle I, G\u00f3mez-Carballa A, et al. Role and diagnostic performance of host epigenome in respiratory morbidity after RSV infection: the EPIRESVi study. Front Immunol. 2022. https:\/\/doi.org\/10.3389\/fimmu.2022.875691.","journal-title":"Front Immunol"},{"issue":"1","key":"974_CR47","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1186\/s12968-021-00792-7","volume":"23","author":"JY Kim","year":"2021","unstructured":"Kim JY, Han K, Suh YJ. Prevalence of abnormal cardiovascular magnetic resonance findings in recovered patients from COVID-19: a systematic review and meta-analysis. J Cardiovasc Magn Reson. 2021;23(1):100.","journal-title":"J Cardiovasc Magn Reson"},{"key":"974_CR48","unstructured":"Guardado M, Theilacker C, Sato R, et al. Abstract 294\/#310 Sequelae of pneumococcal pneumonia in adults: a systematic literature review. ISPPD. 2022."},{"issue":"1","key":"974_CR49","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/s12979-021-00249-6","volume":"18","author":"B Weinberger","year":"2021","unstructured":"Weinberger B. Vaccination of older adults: influenza, pneumococcal disease, herpes zoster, COVID-19 and beyond. Immun Ageing. 2021;18(1):38.","journal-title":"Immun Ageing"},{"issue":"6","key":"974_CR50","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.1007\/s40121-023-00805-1","volume":"12","author":"J Ramirez","year":"2023","unstructured":"Ramirez J, Carrico R, Wilde A, et al. Diagnosis of respiratory syncytial virus in adults substantially increases when adding sputum, saliva, and serology testing to nasopharyngeal swab RT-PCR. Infect Dis Ther. 2023;12(6):1593\u2013603.","journal-title":"Infect Dis Ther"},{"issue":"2","key":"974_CR51","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1093\/infdis\/jiad012","volume":"228","author":"C Onwuchekwa","year":"2023","unstructured":"Onwuchekwa C, Moreo LM, Menon S, et al. Underascertainment of respiratory syncytial virus infection in adults due to diagnostic testing limitations: a systematic literature review and meta-analysis. J Infect Dis. 2023;228(2):173\u201384.","journal-title":"J Infect Dis"},{"issue":"2","key":"974_CR52","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1007\/s40121-023-00758-5","volume":"12","author":"MH Rozenbaum","year":"2023","unstructured":"Rozenbaum MH, Judy J, Tran D, Yacisin K, Kurosky SK, Begier E. Low levels of RSV testing among adults hospitalized for lower respiratory tract infection in the United States. Infect Dis Ther. 2023;12(2):677\u201385.","journal-title":"Infect Dis Ther"},{"issue":"10","key":"974_CR53","doi-asserted-by":"publisher","first-page":"1548","DOI":"10.3201\/eid1210.051015","volume":"12","author":"LA Prosser","year":"2006","unstructured":"Prosser LA, Bridges CB, Uyeki TM, et al. Health benefits, risks, and cost-effectiveness of influenza vaccination of children. Emerg Infect Dis. 2006;12(10):1548\u201358.","journal-title":"Emerg Infect Dis"},{"issue":"7","key":"974_CR54","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0022308","volume":"6","author":"LA Prosser","year":"2011","unstructured":"Prosser LA, Lavelle TA, Fiore AE, et al. Cost-effectiveness of 2009 pandemic influenza A(H1N1) vaccination in the United States. PLoS ONE. 2011;6(7):e22308.","journal-title":"PLoS ONE"},{"issue":"1","key":"974_CR55","doi-asserted-by":"publisher","first-page":"e58","DOI":"10.1016\/S2214-109X(18)30422-4","volume":"7","author":"C Chen","year":"2019","unstructured":"Chen C, Cervero Liceras F, Flasche S, et al. Effect and cost-effectiveness of pneumococcal conjugate vaccination: a global modelling analysis. Lancet Glob Health. 2019;7(1):e58\u201367.","journal-title":"Lancet Glob Health"},{"issue":"3","key":"974_CR56","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1007\/s40121-022-00588-x","volume":"11","author":"K Owusu-Edusei","year":"2022","unstructured":"Owusu-Edusei K, Deb A, Johnson KD. Estimates of the health and economic burden of pneumococcal infections attributable to the 15-valent pneumococcal conjugate vaccine serotypes in the USA. Infect Dis Ther. 2022;11(3):987\u201399.","journal-title":"Infect Dis Ther"},{"issue":"50","key":"974_CR57","doi-asserted-by":"publisher","first-page":"7312","DOI":"10.1016\/j.vaccine.2022.10.066","volume":"40","author":"AR Wateska","year":"2022","unstructured":"Wateska AR, Patricia Nowalk M, Lin CJ, et al. Cost-effectiveness of revised US pneumococcal vaccination recommendations in underserved minority adults < 65-years-old. Vaccine. 2022;40(50):7312\u201320.","journal-title":"Vaccine"},{"issue":"4","key":"974_CR58","first-page":"1683","volume":"11","author":"KJ Smith","year":"2022","unstructured":"Smith KJ, Wateska AR, Nowalk MP, et al. Cost-effectiveness of newly recommended pneumococcal vaccination strategies in older underserved minority adults in the USA. Infect Dis Ther. 2022;11(4):1683\u201393.","journal-title":"Infect Dis Ther"}],"container-title":["Infectious Diseases and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40121-024-00974-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40121-024-00974-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40121-024-00974-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,2]],"date-time":"2024-07-02T02:03:18Z","timestamp":1719885798000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40121-024-00974-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,6]]},"references-count":58,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2024,7]]}},"alternative-id":["974"],"URL":"https:\/\/doi.org\/10.1007\/s40121-024-00974-7","relation":{},"ISSN":["2193-8229","2193-6382"],"issn-type":[{"value":"2193-8229","type":"print"},{"value":"2193-6382","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,6]]},"assertion":[{"value":"24 January 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 April 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 May 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Bradford D. Gessner, Daniel Curcio, Mark Rozenbaum, Samantha K. Kurosky, and Elizabeth Begier are employees of Pfizer and may own Pfizer stock. Egbe Ubamadu, Estefania Betancur, Sonia Menon, Hilde Vroling, and Zuleika Aponte are employees of P95, which was a paid contractor to Pfizer in connection with the development of this manuscript. Sonia Menon affiliated with Epitech Research was an employee of P95 at the time this research was performed.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article is based on previously conducted studies and does not contain any new studies with human participants or animals performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}